MX2025003151A - Nuevas moleculas de union al receptor de colecistocinina 2 derivadas de minigastrina para obtencion de imagenes y radioterapia dirigida - Google Patents

Nuevas moleculas de union al receptor de colecistocinina 2 derivadas de minigastrina para obtencion de imagenes y radioterapia dirigida

Info

Publication number
MX2025003151A
MX2025003151A MX2025003151A MX2025003151A MX2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A MX 2025003151 A MX2025003151 A MX 2025003151A
Authority
MX
Mexico
Prior art keywords
sub
amino acid
minigastrin
imaging
novel
Prior art date
Application number
MX2025003151A
Other languages
English (en)
Spanish (es)
Inventor
THOMAS GüNTHER
Nadine Holzleitner
Wester Hans Jürgen
Constantin Lapa
Original Assignee
Univ Muenchen Tech
Univ Augsburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Muenchen Tech, Univ Augsburg filed Critical Univ Muenchen Tech
Publication of MX2025003151A publication Critical patent/MX2025003151A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
MX2025003151A 2022-09-20 2025-03-18 Nuevas moleculas de union al receptor de colecistocinina 2 derivadas de minigastrina para obtencion de imagenes y radioterapia dirigida MX2025003151A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22196630 2022-09-20
PCT/EP2023/063469 WO2024061483A1 (en) 2022-09-20 2023-05-19 Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy

Publications (1)

Publication Number Publication Date
MX2025003151A true MX2025003151A (es) 2025-04-02

Family

ID=83994946

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025003151A MX2025003151A (es) 2022-09-20 2025-03-18 Nuevas moleculas de union al receptor de colecistocinina 2 derivadas de minigastrina para obtencion de imagenes y radioterapia dirigida

Country Status (9)

Country Link
EP (2) EP4590347A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025532619A (cg-RX-API-DMAC7.html)
KR (1) KR20250073200A (cg-RX-API-DMAC7.html)
CN (1) CN119907695A (cg-RX-API-DMAC7.html)
AU (1) AU2023345654A1 (cg-RX-API-DMAC7.html)
CA (1) CA3264385A1 (cg-RX-API-DMAC7.html)
IL (1) IL319379A (cg-RX-API-DMAC7.html)
MX (1) MX2025003151A (cg-RX-API-DMAC7.html)
WO (1) WO2024061483A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12642876B1 (en) 2025-10-30 2026-06-02 Perspective Therapeutics, Inc. Cholecystokinin-2 receptor targeted compounds and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3412303A1 (en) * 2017-06-08 2018-12-12 Medizinische Universität Innsbruck Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy
KR20240027896A (ko) * 2017-07-28 2024-03-04 테크니쉐 우니베르지테트 뮌헨 이중 모드 방사성 트레이서 및 치료법
EP4023250A1 (en) * 2021-01-04 2022-07-06 Technische Universität München Dual mode radiotracer and -therapeutics

Also Published As

Publication number Publication date
KR20250073200A (ko) 2025-05-27
CA3264385A1 (en) 2024-03-28
CN119907695A (zh) 2025-04-29
JP2025532619A (ja) 2025-10-01
AU2023345654A1 (en) 2025-02-27
WO2024061483A1 (en) 2024-03-28
EP4590347A1 (en) 2025-07-30
IL319379A (en) 2025-05-01
EP4631959A3 (en) 2025-12-17
EP4631959A2 (en) 2025-10-15

Similar Documents

Publication Publication Date Title
CA2437983A1 (en) Transporters comprising spaced arginine moieties
Lejczak et al. Antibacterial activity of phosphono dipeptides related to alafosfalin
DK2496596T3 (en) THERAPEUTIC PEPTIDES
JP2016527186A5 (cg-RX-API-DMAC7.html)
WO2004016274B1 (en) Novel peptide-conjugated oligomeric compounds
RU2015148032A (ru) Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
DE69417049D1 (de) Hydroxamsäurederivate als inhibitoren von cylokine produktion
MX2022002696A (es) Composiciones de peptoides antivirales.
HRP950276A2 (en) New amino acid derivatives, process for their preparation and pharmaceutical compounds (ii) containing such compounds
AU2009292741B8 (en) Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
RU2015100521A (ru) Новые циклические депсипептидные производные и средства для борьбы с вредными организмами, включающие такие производные
HK1216029A1 (zh) β-发夹肽模拟物
JPWO2022191283A5 (cg-RX-API-DMAC7.html)
WO2020167831A1 (en) Method of preparing a don prodrug from l-glutamic acid
EA014959B3 (ru) Ингибиторы глицинового переносчика-1
EP2421893A2 (en) Short-chain peptides as parathyroid hormone (pth) receptor agonist
US6753431B2 (en) Production of mixed acid anhydride and amide compound
AU2013277637B2 (en) Synthesis of beta-turn peptidomimetic cyclic compounds
DE602004029497D1 (de) Neue proteasommodulatoren
EA200400603A1 (ru) Новые пептиды - аналоги гормона высвобождения гормона роста человека
US20220185841A1 (en) Method for producing peptide compound, reagent for forming protective group, and hydrazine derivative
DK1144421T3 (da) Phosphiniske pseudopeptider, som er inhibitorer af matrix-metalloproteaser
CA3228897A1 (en) Polypeptide drug conjugate having novel structure and application thereof
PL441789A1 (pl) Lipooligomoczniki, kompozycja farmaceutyczna, oraz lipooligomoczniki do zastosowania jako lek
Rodrigues et al. Synthesis and conformational investigation of tetrapeptide analogues of the fragment B23-B26 of insulin